Tiny trial tests new injectable implant in just 2 volunteers
NCT ID NCT07151638
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early trial tested the safety of a new injectable medical device called Fractomer Biomatrix in just 2 healthy volunteers. The device is designed to support soft tissue, but the main goal was to see if it causes any side effects. Participants received a single injection under the skin, and the implant was later removed. The study is currently suspended, so results are very limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fractomer Biomatrix (injectable, bioresorbable medical device)
What this could lead to
If safe, this could pave the way for a new injectable material to support soft tissue repair.
What could go wrong
This is a very early, tiny safety study (only 2 participants) that is currently suspended. It does not test effectiveness, and the implant is removed after monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBCUTANEOUS INJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Saint Paul, Minnesota, 55114, United States